As of 2025-01-18, the Relative Valuation of CVS Health Corp (CVS) is 107.18 USD. This relative valuation is based on P/E multiples. With the latest stock price at 52.62 USD, the upside of CVS Health Corp based on Relative Valuation is 103.7%.
The range of the Relative Valuation is 88.97 - 133.75 USD.
| Range | Selected | |
| Trailing P/E multiples | 22.3x - 26.6x | 24.9x |
| Forward P/E multiples | 16.7x - 19.5x | 16.8x |
| Fair Price | 88.97 - 133.75 | 107.18 |
| Upside | 69.1% - 154.2% | 103.7% |
| Date | P/E |
| 2025-01-17 | 13.20 |
| 2025-01-16 | 13.04 |
| 2025-01-15 | 13.08 |
| 2025-01-14 | 12.94 |
| 2025-01-13 | 12.93 |
| 2025-01-10 | 12.04 |
| 2025-01-08 | 11.54 |
| 2025-01-07 | 11.49 |
| 2025-01-06 | 11.50 |
| 2025-01-03 | 11.48 |
| 2025-01-02 | 11.09 |
| 2024-12-31 | 11.26 |
| 2024-12-30 | 11.02 |
| 2024-12-27 | 11.16 |
| 2024-12-26 | 11.27 |
| 2024-12-24 | 11.10 |
| 2024-12-23 | 11.07 |
| 2024-12-20 | 11.13 |
| 2024-12-19 | 10.98 |
| 2024-12-18 | 11.36 |
| 2024-12-17 | 11.05 |
| 2024-12-16 | 11.69 |
| 2024-12-13 | 12.39 |
| 2024-12-12 | 12.44 |
| 2024-12-11 | 12.99 |
| 2024-12-10 | 13.84 |
| 2024-12-09 | 14.07 |
| 2024-12-06 | 13.87 |
| 2024-12-05 | 14.26 |
| 2024-12-04 | 14.56 |
| 2024-12-03 | 14.85 |
| 2024-12-02 | 14.82 |
| 2024-11-29 | 15.02 |
| 2024-11-27 | 15.04 |
| 2024-11-26 | 14.80 |
| 2024-11-25 | 15.07 |
| 2024-11-22 | 14.55 |
| 2024-11-21 | 14.33 |
| 2024-11-20 | 14.26 |
| 2024-11-19 | 13.99 |
| 2024-11-18 | 14.06 |
| 2024-11-15 | 13.34 |
| 2024-11-14 | 13.82 |
| 2024-11-13 | 13.62 |
| 2024-11-12 | 13.56 |
| 2024-11-11 | 14.00 |
| 2024-11-08 | 13.93 |
| 2024-11-07 | 14.32 |
| 2024-11-06 | 15.46 |
| 2024-11-05 | 13.88 |